# Desvenlafaxine

NDC: 10135-821
Generic name: Desvenlafaxine
Labeler / Manufacturer: Marlex Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250701

FDA application: ANDA204805

## Active ingredients

- DESVENLAFAXINE SUCCINATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-821"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-821
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=387cea91-6924-2a68-e063-6394a90a8f75